<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Manganese: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Manganese: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Manganese: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="9586" href="/d/html/9586.html" rel="external">see "Manganese: Drug information"</a> and <a class="drug drug_patient" data-topicid="12073" href="/d/html/12073.html" rel="external">see "Manganese: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F807895"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Mangimin [OTC] [DSC]</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52867428"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Micro-Mn</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F1023313"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Dietary Supplement</span>;</li>
<li>
<span class="list-set-name">Trace Element, Parenteral</span></li></ul></div>
<div class="block don drugH1Div" id="F57643722"><span class="drugH1">Dosing: Neonatal</span>
<p style="text-indent:0em;display:inline">
<b>Note: </b>Dosing presented as mcg/<b>kg</b>/day and mcg/day; use caution.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Adequate intake (AI): Note:</b> Recommended intake from dietary sources (eg, breast milk, formula).</p>
<p style="text-indent:-2em;margin-left:4em;">Neonates: Oral: 3 mcg/day (IOM 2001; NIH 2021).</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c6ddc184-6e5a-4727-9f62-02484be5592f">Parenteral nutrition additive, maintenance requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition (PN) additive, maintenance requirement:</b>
<b>Note: </b>Manganese contamination is common with other PN products (eg, sodium phosphate, magnesium sulfate), which decreases or eliminates the need for routine supplementation; some experts suggest that additional supplementation is likely unnecessary (ASPEN [Corkins 2015]; ASPEN [Mirtallo 2004]; ESPGHAN/ESPEN/ESPR/CSPEN [Domellöf 2018]; Olson 2019; Srikrishnaraj 2021).</p>
<p style="text-indent:-2em;margin-left:4em;">Term and Preterm Neonates: IV: 1 mcg/<b>kg</b>/day (ASPEN 2020; ASPEN [Corkins 2015]; ASPEN [Mirtallo 2004]).</p></div>
</div>
</div>
<div class="block dop drugH1Div" id="F191243"><span class="drugH1">Dosing: Pediatric</span>
<p style="text-indent:0em;display:inline">
<b>Note: </b>Dosing presented as mcg/<b>kg</b>/day and mcg/day; use caution.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c6ddc184-6e5a-4727-9f62-02484be5592f">Parenteral nutrition additive, maintenance requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition (PN) additive, maintenance requirement: </b>
<b>Note: </b>Manganese contamination is common with other PN products (eg, sodium phosphate, magnesium sulfate), which decreases or eliminates the need for routine supplementation; some experts suggest that additional supplementation is likely unnecessary (ASPEN [Corkins 2015]; ASPEN [Mirtallo 2004]; ESPGHAN/ESPEN/ESPR/CSPEN [Domellöf 2018]; Olson 2019; Srikrishnaraj 2021).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>ASPEN recommendations:</i></p>
<p style="text-indent:-2em;margin-left:6em;">Infant and Children weighing ≤40 kg: IV: 1 mcg/<b>kg</b>/day; maximum daily dose: 55 mcg/<b>day</b> (ASPEN 2020; ASPEN [Corkins 2015]; ASPEN [Mirtallo 2004]).</p>
<p style="text-indent:-2em;margin-left:6em;">Children and Adolescents weighing &gt;40 kg: IV: 40 to 100 mcg/day (ASPEN 2020; ASPEN [Corkins 2015]; ASPEN [Mirtallo 2004]).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>ESPGHAN/ESPEN/ESPR/CSPEN recommendations:</i> Infants, Children, and Adolescents: IV: ≤1 mcg/<b>kg</b>/day; maximum daily dose: 50 mcg/<b>day</b> (Domellöf 2018).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51130170"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. Use caution; manganese chloride solution for injection contains aluminum.</p></div>
<div class="block dohp drugH1Div" id="F51130171"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. Use caution; dose may need to be decreased or withheld in patients with hepatobiliary disease.</p></div>
<div class="block doa drugH1Div" id="F191236"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="9586" href="/d/html/9586.html" rel="external">see "Manganese: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="81863c66-ac4f-45ff-b638-ded564c6efe2">Dietary supplement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dietary supplement: Oral: </b>1 capsule/tablet daily.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e69afa9e-557e-43f1-9b39-f55cc1e5831e">Parenteral nutrition, maintenance requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b> Parenteral nutrition, maintenance requirement:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note: </b>Parenteral nutrition ordering requires advanced knowledge of nutrient and other metabolic requirements and should only be prescribed by clinicians trained in assessment and order writing for parenteral nutrition (ASPEN [Guenter 2015]).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Standard daily manganese requirement</i>
<b>
<i>:</i></b>
<b>IV:</b> Elemental manganese 55 mcg daily as component of parenteral nutrition; adjust daily dose based on serum manganese and clinical considerations (ASPEN 2019).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990458"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. Use caution; manganese chloride solution for injection contains aluminum.</p></div>
<div class="block doha drugH1Div" id="F50987682"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. Use caution; dose may need to be discontinued in patients who develop signs and symptoms of hepatobiliary disease (eg, cholestasis, cirrhosis).</p></div>
<div class="block adr drugH1Div" id="F56668591"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">There are no adverse reactions listed in the manufacturer's labeling.</p></div>
<div class="block coi drugH1Div" id="F191229"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">There are no contraindications listed within the manufacturer's US labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>Canadian labeling:</i> Hypersensitivity to manganese or any component of the formulation.</p></div>
<div class="block war drugH1Div" id="F191216"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Concerns related to adverse effects:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Neurotoxicity: Neuropsychiatric symptoms, including dysarthria, halting gait, mask-face, memory changes, mood changes, parkinsonian-like tremors, and seizures, have primarily been reported in patients on long-term therapy receiving higher than recommended doses and in association with cholestatic liver disease due to accumulation of manganese in the basal ganglia; has also been reported in patients on recommended doses with normal blood manganese concentrations. Symptoms usually resolved over weeks to months after discontinuation of therapy but may not completely resolve.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Hepatobiliary disease: Use with caution in patients with hepatobiliary disorders (eg, cholecystitis, cirrhosis); may increase risk of manganese brain deposits and neurotoxicity, especially in patients on long-term therapy or higher than recommended dosages. Consider discontinuation of therapy in patients that develop signs or symptoms of hepatobiliary disease until clinical evaluation is complete.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Aluminum: The parenteral product may contain aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or renal dysfunction. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of &gt;4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses (Federal Register 2002). See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Parenteral: Due to its highly acidic pH (pH 2.0), direct IV or IM injection is contraindicated; may result in severe tissue damage. Use only in conjunction with an admixture program.</p></div>
<div class="block foc drugH1Div" id="F191223"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous, as chloride: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Elemental manganese 0.1 mg/mL (10 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous, as sulfate [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Elemental manganese 0.1 mg/mL (10 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral, as chelated: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Mangimin: Elemental manganese 10 mg [DSC] [corn free, rye free, wheat free]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Elemental manganese 50 mg</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral, as gluconate: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 50 mg [elemental manganese 5.7 mg]</p></div>
<div class="block geq drugH1Div" id="F191212"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F16323359"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Manganese Chloride Intravenous)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1 mg/mL (per mL): $4.07</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Manganese Gluconate Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">50 mg (per each): $0.06</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52867429"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous, as sulfate: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Micro-Mn: Elemental manganese 0.1 mg/mL (10 mL)</p></div>
<div class="block admp drugH1Div" id="F52613220"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Parenteral: Not for direct IV or IM injection; must be diluted in parenteral nutrition solution prior to administration; acidic pH of the solution may cause tissue irritation and it is hypotonic.</p></div>
<div class="block adm drugH1Div" id="F191226"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral:</b> May be administered with a meal.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>IV:</b> Do not administer IM or by direct IV injection; must be diluted in parenteral nutrition solution prior to administration (volume of fluid ≥100 mL). Acidic pH of the solution may cause tissue irritations and it is hypotonic.</p></div>
<div class="block sts drugH1Div" id="F191234"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:-2em;margin-left:2em;">Capsule/tablet (dietary supplement): Store at room temperature, away from heat and direct light. Do not freeze or refrigerate.</p>
<p style="text-indent:-2em;margin-left:2em;">Injection: Store intact vial at 20°C to 25°C (68°F to 77°F). After admixture, discard unused portion immediately.</p></div>
<div class="block usep drugH1Div" id="F53567663"><span class="drugH1">Use</span>
<p style="text-indent:-2em;margin-left:2em;">Parenteral: Supplement to parenteral nutrition (PN) to maintain manganese serum concentrations and to prevent depletion of endogenous stores and subsequent deficiency (FDA approved in pediatric patients [age not specified] and adults).</p>
<p style="text-indent:-2em;margin-left:2em;">Oral: Dietary supplement of manganese (Dietary supplement; consult product-specific labeling for manufacturer recommended ages).</p></div>
<div class="block mst drugH1Div" id="F191249"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Manganese sulfate may be confused with magnesium sulfate</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13299643"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F6221444"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block dic drugH1Div" id="F50968322"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dietary adequate intake (IOM 2001): </b></p>
<p style="text-indent:-2em;margin-left:4em;">1 to 6 months: 0.003 mg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">7 to 12 months: 0.6 mg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">1 to 3 years: 1.2 mg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">4 to 8 years: 1.5 mg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">9 to 13 years:</p>
<p style="text-indent:-2em;margin-left:6em;">Males: 1.9 mg/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Females: 1.6 mg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">14 to 18 years:</p>
<p style="text-indent:-2em;margin-left:6em;">Males: 2.2 mg/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Females: 1.6 mg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">&gt;18 years:</p>
<p style="text-indent:-2em;margin-left:6em;">Males: 2.3 mg/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Females: 1.8 mg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">Pregnancy: 2 mg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">Lactation: 2.6 mg/day.</p></div>
<div class="block pri drugH1Div" id="F14207726"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Animal reproduction studies have not been conducted. Manganese crosses the placenta and can be detected in placental tissue and cord blood (Osada 2002).</p></div>
<div class="block mopp drugH1Div" id="F53567639"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Periodic manganese plasma level.</p></div>
<div class="block rerp drugH1Div" id="F53567530"><span class="drugH1">Reference Range</span>
<p style="text-indent:0em;display:inline">Whole blood: 6 to 12 mcg/L.</p></div>
<div class="block pha drugH1Div" id="F191215"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Cofactor in many enzyme systems, stimulates synthesis of cholesterol and fatty acids in liver, and influences mucopolysaccharide synthesis</p></div>
<div class="block phk drugH1Div" id="F191228"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Poor.</p>
<p style="text-indent:-2em;margin-left:2em;">Distribution: Concentrated in mitochondria of brain, pituitary gland, pancreas, liver, kidney, and bone.</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Bile (primarily); urine (negligible).</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F56519913"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Manganes mn</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Hypo 11a Mangan | Mangan | Mangan GPH</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Kelasin mn</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Mangaplexe</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Mangana</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Manganas homeoligo</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Solgar chelated manganese</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Chelated manganese</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-ASPEN.1">
<a name="ASPEN.1"></a>American Society for Parenteral and Enteral Nutrition (ASPEN). Appropriate dosing for parenteral nutrition. http://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resources/PN%20Dosing%201-Sheet-FINAL.pdf. Published January 8, 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ASPEN.2">
<a name="ASPEN.2"></a>American Society for Parenteral and Enteral Nutrition (ASPEN). Appropriate dosing for parenteral nutrition: ASPEN recommendations. http://www.nutritioncare.org/PNDosing. Updated November 17, 2020. Accessed January 10, 2023.</div>
</li>
<li>
<div class="reference">
                  Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Fed Regist</i>. 2002;67(244):77792-77793. To be codified at 21 CFR §201.323.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35365361">
<a name="35365361"></a>Berger MM, Shenkin A, Schweinlin A, et al. ESPEN micronutrient guideline. <i>Clin Nutr</i>. 2022;41(6):1357-1424. doi:10.1016/j.clnu.2022.02.015<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/manganese-pediatric-drug-information/abstract-text/35365361/pubmed" id="35365361" target="_blank">35365361</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Corkins.1">
<a name="Corkins.1"></a>Corkins MR, Balint J, Corkins KG, Bobo E, Plogsted S, Yaworski, JA, eds. <i>A.S.P.E.N. Pediatric Nutrition Support Handbook</i>. 2nd ed. American Society for Enteral and Parenteral Nutrition; 2015:chap. 35.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30078716">
<a name="30078716"></a>Domellöf M, Szitanyi P, Simchowitz V, Franz A, Mimouni F; ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Iron and trace minerals. <i>Clin Nutr</i>. 2018;37(6 Pt B):2354-2359. doi:10.1016/j.clnu.2018.06.949<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/manganese-pediatric-drug-information/abstract-text/30078716/pubmed" id="30078716" target="_blank">30078716</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26078288">
<a name="26078288"></a>Guenter P, Boullata JI, Ayers P, et al; Parenteral Nutrition Safety Task Force, American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). Standardized competencies for parenteral nutrition prescribing: the American Society for Parenteral and Enteral Nutrition model. <i>Nutr Clin Pract</i>. 2015;30(4):570-576. doi:10.1177/0884533615591167<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/manganese-pediatric-drug-information/abstract-text/26078288/pubmed" id="26078288" target="_blank">26078288</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Institute of Medicine (IOM) (US) Panel on Micronutrients. <i>Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc</i>. National Academies Press; 2001. <a href="https://www.ncbi.nlm.nih.gov/books/NBK222310/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK222310/</a>
</div>
</li>
<li>
<div class="reference">
                  Manganese 50 mg capsules [prescribing information]. Salt Lake City, UT: Solaray; received October 2022.</div>
</li>
<li>
<div class="reference">
                  Manganese 50 mg tablets [prescribing information]. Ronkonkoma, NY; PipingRock; received October 2022.</div>
</li>
<li>
<div class="reference">
                  Manganese chloride injection [prescribing information]. Lake Forest, IL: Hospira Inc; December 2023.</div>
</li>
<li>
<div class="reference">
                  MICRO MN (manganese) [product monograph]. Boucherville, Quebec, Canada: Sandoz Canada Inc; January 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15568296">
<a name="15568296"></a>Mirtallo J, Canada T, Johnson D, et al; Task Force for the Revision of Safe Practices for Parenteral Nutrition. Safe practices for parenteral nutrition. <i>JPEN J Parenter Enteral Nutr</i>. 2004;28(6):S39-S70. doi:10.1177/0148607104028006s39<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/manganese-pediatric-drug-information/abstract-text/15568296/pubmed" id="15568296" target="_blank">15568296</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NIH.1">
<a name="NIH.1"></a>National Institutes of Health (NIH). Manganese: fact sheet for health professionals. <a href="https://ods.od.nih.gov/factsheets/Manganese-HealthProfessional/" target="_blank">https://ods.od.nih.gov/factsheets/Manganese-HealthProfessional/</a>. Updated March 29, 2021. Accessed December 4, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31197862">
<a name="31197862"></a>Olson LM, Wieruszewski PM, Jannetto PJ, Abbott JC, McMahon MM, Nystrom EM. Quantitative assessment of trace-element contamination in parenteral nutrition components. <i>JPEN J Parenter Enteral Nutr</i>. 2019;43(8):970-976. doi:10.1002/jpen.1668<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/manganese-pediatric-drug-information/abstract-text/31197862/pubmed" id="31197862" target="_blank">31197862</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12366483">
<a name="12366483"></a>Osada H, Watanabe Y, Nishimura Y, et al, "Profile of Trace Element Concentrations in the Feto-Placental Unit in Relation to Fetal Growth," <i>Acta Obstet Gynecol Scand</i>, 2002, ;81(10):931-7.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/manganese-pediatric-drug-information/abstract-text/12366483/pubmed" id="12366483" target="_blank">12366483</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32338772">
<a name="32338772"></a>Srikrishnaraj A, Chambers K, South C, et al. Trace elements' contamination of pediatric parenteral nutrition solutions in Canada: a cause for concern. <i>JPEN J Parenter Enteral Nutr</i>. 2021;45(2):347-356. doi:10.1002/jpen.1836<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/manganese-pediatric-drug-information/abstract-text/32338772/pubmed" id="32338772" target="_blank">32338772</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22730042">
<a name="22730042"></a>Vanek VW, Borum P, Buchman A, et al. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. <i>Nutr Clin Pract</i>. 2012;27:440-491.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/manganese-pediatric-drug-information/abstract-text/22730042/pubmed" id="22730042" target="_blank">22730042</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 140499 Version 14.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
